California § 1367.665 - A health care service plan contract, except for a specialized health care service
Full text of California Public Contract Code - PCC § 1367.665 — A health care service plan contract, except for a specialized health care service, with citation guidance and answers to common questions.
§ 1367.665. A health care service plan contract, except for a specialized health care service
(a) A health care service plan contract, except for a specialized health care service plan contract, that is issued, amended, delivered, or renewed on or after July 1, 2000, shall be deemed to provide coverage for all generally medically accepted cancer screening tests, subject to all terms and conditions that would otherwise apply. (b) (1) A health care service plan contract, except for a specialized health care service plan contract, that is issued, amended, delivered, or renewed on or after July 1, 2022, shall not require prior authorization for either of the following: (A) Biomarker testing for an enrollee with advanced or metastatic stage 3 or 4 cancer. (B) Biomarker testing for cancer progression or recurrence in the enrollee with advanced or metastatic stage 3 or 4 cancer. (2) This subdivision shall also apply to health care service plan contracts and Medi-Cal managed care plan contracts with the State Department of Health Care Services pursuant to Chapter 7 (commencing with Section 14000) or Chapter 8 (commencing with Section 14200) of Part 3 of Division 9 of the Welfare and Institutions Code. (c) For purposes of this section, âbiomarker testâ means a diagnostic test, such as single or multigene, of the cancer patientâs biospecimen, such as tissue, blood, or other bodily fluids, for DNA or RNA alterations, including phenotypic characteristics of a malignancy, to identify an individual with a subtype of cancer, in order to guide patient treatment. (d) Notwithstanding subdivision (b), this section does not prohibit a health care service plan from requiring prior authorization on biomarker testing that is not for an FDA-approved therapy for advanced or metastatic stage 3 or 4 cancer. (e) This section does not limit, prohibit, or modify an enrolleeâs rights to biomarker testing as part of an approved clinical trial under Section 1370.6.
Source: official California text · Last verified 2026-08-27
Frequently Asked Questions About California § 1367.665
What does Public Contract Code - PCC § 1367.665 cover?
Section 1367.665 ("A health care service plan contract, except for a specialized health care service") is part of the Public Contract Code - PCC, the codified statutory law of California. It sets out the legal rule or procedure described in the text above. Statutes are amended regularly, so always verify against the official source.
How do I cite California § 1367.665?
A common citation format is "Public Contract Code - PCC § 1367.665" (California). Legal writing may require the code abbreviation, section number, and year or edition. Match the style required by your court, professor, or publisher.
Is this the official text of California law?
No. This page is for research and education and may not include the most recent amendments. For official current law, check the California official source linked on this page or consult a licensed California attorney.
How does California § 1367.665 apply to my situation?
Statutes are interpreted in context, and application depends on your specific facts. Only a licensed attorney in California can advise on how this section applies to you. Contact your state or local bar association for a referral.
Sources & Verification
Not legal advice. Verify against the official source and consult a licensed attorney in California.